| EVAMPLIX (BALSTILIMAB) Agenus Inc. 2253300 19 Jan 2022 | Cancelled: Cancelled at the request of IB | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases. | |
| EVAMPLIX Agenus Inc. 2033697 1 Jul 2019 | Cancelled: Cancelled at the request of IB | Pharmaceutical, therapeutic and biopharmaceutical agents for the treat... Class 005 Class 005 Pharmaceutical Products Pharmaceutical, therapeutic and biopharmaceutical agents for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; pharmaceutical, therapeutic and biopharmaceutical preparations and substances for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases; biological preparations, namely, antibodies for the treatment of cancer, infectious diseases, autoimmune disorders, transplant rejections, and inflammatory diseases. | |
